UBS AM’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,490	Closed	-$2.76M	–	2791
2021 Q1	$2.76M	Sell	9,490 -125	-1%	-$36.3K	﹤0.01%	1623
2020 Q4	$6M	Buy	+9,615	New	+$6M	﹤0.01%	1219